Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2017-2028

2.1.2 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Postmenopausal Vaginal Atrophy (PVA) Treatment Segment by Type

2.2.1 Systemic Estrogen Treatments

2.2.2 Non-estrogenic Therapies

2.3 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type

2.3.1 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Type (2017-2022)

2.4 Postmenopausal Vaginal Atrophy (PVA) Treatment Segment by Application

2.4.1 Hospital

2.4.2 Clinics

2.5 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application

2.5.1 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Application (2017-2022)

3 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Player

3.1 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Players

3.1.1 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue by Players (2020-2022)

3.1.2 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Postmenopausal Vaginal Atrophy (PVA) Treatment by Regions

4.1 Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Regions (2017-2022)

4.2 Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth (2017-2022)

4.3 APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth (2017-2022)

4.4 Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Country (2017-2022)

5.2 Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2017-2022)

5.3 Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Region (2017-2022)

6.2 APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2017-2022)

6.3 APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Postmenopausal Vaginal Atrophy (PVA) Treatment by Country (2017-2022)

7.2 Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2017-2022)

7.3 Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment by Region (2017-2022)

8.2 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.1 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast by Regions (2023-2028)

10.1.1 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast

10.1.3 APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast

10.1.4 Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast

10.1.5 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast

10.2 Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast by Country (2023-2028)

10.2.1 United States Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.2.2 Canada Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.2.3 Mexico Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.2.4 Brazil Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.3 APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast by Region (2023-2028)

10.3.1 China Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.3.2 Japan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.3.3 Korea Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.3.4 Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.3.5 India Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.3.6 Australia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.4 Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast by Country (2023-2028)

10.4.1 Germany Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.4.2 France Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.4.3 UK Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.4.4 Italy Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.4.5 Russia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.5 Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.5.2 South Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.5.3 Israel Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.5.4 Turkey Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.5.5 GCC Countries Postmenopausal Vaginal Atrophy (PVA) Treatment Market Forecast

10.6 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast by Type (2023-2028)

10.7 Global Postmenopausal Vaginal Atrophy (PVA) Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 EndoCeutics

11.1.1 EndoCeutics Company Information

11.1.2 EndoCeutics Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.1.3 EndoCeutics Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 EndoCeutics Main Business Overview

11.1.5 EndoCeutics Latest Developments

11.2 Upsher-Smith Laboratories

11.2.1 Upsher-Smith Laboratories Company Information

11.2.2 Upsher-Smith Laboratories Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.2.3 Upsher-Smith Laboratories Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Upsher-Smith Laboratories Main Business Overview

11.2.5 Upsher-Smith Laboratories Latest Developments

11.3 TherapeuticsMD

11.3.1 TherapeuticsMD Company Information

11.3.2 TherapeuticsMD Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.3.3 TherapeuticsMD Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 TherapeuticsMD Main Business Overview

11.3.5 TherapeuticsMD Latest Developments

11.4 Bionovo

11.4.1 Bionovo Company Information

11.4.2 Bionovo Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.4.3 Bionovo Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Bionovo Main Business Overview

11.4.5 Bionovo Latest Developments

11.5 Pfizer

11.5.1 Pfizer Company Information

11.5.2 Pfizer Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.5.3 Pfizer Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Pfizer Main Business Overview

11.5.5 Pfizer Latest Developments

11.6 Novo Nordisk

11.6.1 Novo Nordisk Company Information

11.6.2 Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.6.3 Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Novo Nordisk Main Business Overview

11.6.5 Novo Nordisk Latest Developments

11.7 Allergan

11.7.1 Allergan Company Information

11.7.2 Allergan Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.7.3 Allergan Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Allergan Main Business Overview

11.7.5 Allergan Latest Developments

11.8 Shionogi

11.8.1 Shionogi Company Information

11.8.2 Shionogi Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.8.3 Shionogi Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Shionogi Main Business Overview

11.8.5 Shionogi Latest Developments

11.9 Ligand Pharmaceuticals

11.9.1 Ligand Pharmaceuticals Company Information

11.9.2 Ligand Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.9.3 Ligand Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Ligand Pharmaceuticals Main Business Overview

11.9.5 Ligand Pharmaceuticals Latest Developments

11.10 Bayer

11.10.1 Bayer Company Information

11.10.2 Bayer Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.10.3 Bayer Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Bayer Main Business Overview

11.10.5 Bayer Latest Developments

11.11 Pantarhei Bioscience

11.11.1 Pantarhei Bioscience Company Information

11.11.2 Pantarhei Bioscience Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.11.3 Pantarhei Bioscience Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Pantarhei Bioscience Main Business Overview

11.11.5 Pantarhei Bioscience Latest Developments

11.12 Foamix Pharmaceuticals

11.12.1 Foamix Pharmaceuticals Company Information

11.12.2 Foamix Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.12.3 Foamix Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Foamix Pharmaceuticals Main Business Overview

11.12.5 Foamix Pharmaceuticals Latest Developments

11.13 Pep-Tonic Medical

11.13.1 Pep-Tonic Medical Company Information

11.13.2 Pep-Tonic Medical Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.13.3 Pep-Tonic Medical Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Pep-Tonic Medical Main Business Overview

11.13.5 Pep-Tonic Medical Latest Developments

11.14 Teva Pharmaceuticals

11.14.1 Teva Pharmaceuticals Company Information

11.14.2 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

11.14.3 Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Teva Pharmaceuticals Main Business Overview

11.14.5 Teva Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

Table 1. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Systemic Estrogen Treatments

Table 3. Major Players of Non-estrogenic Therapies

Table 4. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Type (2017-2022)

Table 7. Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Application (2017-2022)

Table 10. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue Market Share by Player (2020-2022)

Table 12. Postmenopausal Vaginal Atrophy (PVA) Treatment Key Players Head office and Products Offered

Table 13. Postmenopausal Vaginal Atrophy (PVA) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Regions (2017-2022)

Table 18. Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Country (2017-2022)

Table 20. Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Type (2017-2022)

Table 22. Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Application (2017-2022)

Table 24. APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Region (2017-2022)

Table 26. APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Type (2017-2022)

Table 28. APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Application (2017-2022)

Table 30. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Country (2017-2022)

Table 32. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Type (2017-2022)

Table 34. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Postmenopausal Vaginal Atrophy (PVA) Treatment

Table 43. Key Market Challenges & Risks of Postmenopausal Vaginal Atrophy (PVA) Treatment

Table 44. Key Industry Trends of Postmenopausal Vaginal Atrophy (PVA) Treatment

Table 45. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 51. EndoCeutics Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 52. EndoCeutics Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 53. EndoCeutics Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. EndoCeutics Main Business

Table 55. EndoCeutics Latest Developments

Table 56. Upsher-Smith Laboratories Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 57. Upsher-Smith Laboratories Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 58. Upsher-Smith Laboratories Main Business

Table 59. Upsher-Smith Laboratories Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Upsher-Smith Laboratories Latest Developments

Table 61. TherapeuticsMD Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 62. TherapeuticsMD Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 63. TherapeuticsMD Main Business

Table 64. TherapeuticsMD Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. TherapeuticsMD Latest Developments

Table 66. Bionovo Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 67. Bionovo Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 68. Bionovo Main Business

Table 69. Bionovo Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Bionovo Latest Developments

Table 71. Pfizer Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 72. Pfizer Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 73. Pfizer Main Business

Table 74. Pfizer Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Pfizer Latest Developments

Table 76. Novo Nordisk Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 77. Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 78. Novo Nordisk Main Business

Table 79. Novo Nordisk Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Novo Nordisk Latest Developments

Table 81. Allergan Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 82. Allergan Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 83. Allergan Main Business

Table 84. Allergan Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Allergan Latest Developments

Table 86. Shionogi Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 87. Shionogi Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 88. Shionogi Main Business

Table 89. Shionogi Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Shionogi Latest Developments

Table 91. Ligand Pharmaceuticals Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 92. Ligand Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 93. Ligand Pharmaceuticals Main Business

Table 94. Ligand Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Ligand Pharmaceuticals Latest Developments

Table 96. Bayer Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 97. Bayer Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 98. Bayer Main Business

Table 99. Bayer Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Bayer Latest Developments

Table 101. Pantarhei Bioscience Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 102. Pantarhei Bioscience Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 103. Pantarhei Bioscience Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Pantarhei Bioscience Main Business

Table 105. Pantarhei Bioscience Latest Developments

Table 106. Foamix Pharmaceuticals Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 107. Foamix Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 108. Foamix Pharmaceuticals Main Business

Table 109. Foamix Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Foamix Pharmaceuticals Latest Developments

Table 111. Pep-Tonic Medical Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 112. Pep-Tonic Medical Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 113. Pep-Tonic Medical Main Business

Table 114. Pep-Tonic Medical Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Pep-Tonic Medical Latest Developments

Table 116. Teva Pharmaceuticals Details, Company Type, Postmenopausal Vaginal Atrophy (PVA) Treatment Area Served and Its Competitors

Table 117. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Product Offered

Table 118. Teva Pharmaceuticals Main Business

Table 119. Teva Pharmaceuticals Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Teva Pharmaceuticals Latest Developments

List of Figures

Figure 1. Postmenopausal Vaginal Atrophy (PVA) Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Type in 2021

Figure 7. Postmenopausal Vaginal Atrophy (PVA) Treatment in Hospital

Figure 8. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Postmenopausal Vaginal Atrophy (PVA) Treatment in Clinics

Figure 10. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Application in 2021

Figure 12. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Revenue Market Share by Player in 2021

Figure 13. Global Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Regions (2017-2022)

Figure 14. Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2017-2022 ($ Millions)

Figure 15. APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2017-2022 ($ Millions)

Figure 16. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2017-2022 ($ Millions)

Figure 17. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Value Market Share by Country in 2021

Figure 19. Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Consumption Market Share by Type in 2021

Figure 20. Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Application in 2021

Figure 21. United States Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 22. Canada Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 23. Mexico Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Brazil Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Region in 2021

Figure 26. APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Application in 2021

Figure 27. China Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 28. Japan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 29. Korea Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. India Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Australia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Country in 2021

Figure 34. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Type in 2021

Figure 35. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Application in 2021

Figure 36. Germany Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 37. France Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 38. UK Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. Italy Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. Russia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Region in 2021

Figure 42. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Type in 2021

Figure 43. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Market Share by Application in 2021

Figure 44. Egypt Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 45. South Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 46. Israel Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. Turkey Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. GCC Country Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Americas Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 50. APAC Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 51. Europe Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 52. Middle East & Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 53. United States Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Canada Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 55. Mexico Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Brazil Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 57. China Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Japan Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 59. Korea Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Southeast Asia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 61. India Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Australia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 63. Germany Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 64. France Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 65. UK Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 66. Italy Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 67. Russia Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Spain Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Egypt Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 70. South Africa Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Israel Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 72. Turkey Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)

Figure 73. GCC Countries Postmenopausal Vaginal Atrophy (PVA) Treatment Market Size 2023-2028 ($ Millions)